돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 432047생성일: 2026년 10월 26일

Sodium Hydroxide → Citalopram

https://huagongshe.com/reaction/432047

반응식

참여 물질

역할이름HCID투입량
반응물Sodium HydroxideHCID 14798—
반응물Potassium bisulfateHCID 516920—
반응물5-Aminomethyl-1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuranHCID 11472927—
촉매Nickel SulfateHCID 24586—
용매DichloromethaneHCID 6344—
생성물CitalopramHCID 2771—

반응 단계

To a stirred solution of 5-aminomethyl-1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran (0.5 g, 1.5 mmol) in dichloromethane (10 mL) was added an aqueous solution of potassium bisulfate and sodium hydroxide (19 mL; 0.2 M in K2S2O8, 3.8 mmol; 0.4 M in NaOH, 7.6 mmol), followed by an aqueous solution of nickel sulfate (1.5 mL, 40 mM, 61 μmol). The mixture was stirred vigorously for 4 days, and was then filtered through celite. The filtrate was partitioned between aqueous sulfuric acid (2 M) and toluene. The aqueous layer was separated, and the pH of the mixture was adjusted to >9 by the addition of aqueous ammonia solution (25% w/v). The solution was extracted with toluene, and this latter toluene extract was dried over magnesium sulfate and evaporated to give the free base of citalopram as a very pale yellow oil (0.35 g, 70%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06660873B2
출처 데이터셋uspto-grants-2003_12
ORD IDord-a18f67ca611c4f07a46a38ae2cef77dd
출처 메모uspto-grants-2003_12